Activation of disease during therapy with alemtuzumab in 3 patients with multiple sclerosis
- DOI
- 10.1212/wnl.0000000000004950
- Published
- 2018-02-13
- Container
- Neurology
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1212/wnl.0000000000004950,
title = {Activation of disease during therapy with alemtuzumab in 3 patients with multiple sclerosis},
author = {Thomas Wehrum and Lena-Alexandra Beume and Oliver Stich and Irina Mader and Mathias Mäurer and Adam Czaplinski and Cornelius Weiller and Sebastian Rauer},
year = {2018},
journal = {Neurology},
doi = {10.1212/wnl.0000000000004950},
url = {https://doi.org/10.1212/wnl.0000000000004950}
}RIS
TY - JOUR TI - Activation of disease during therapy with alemtuzumab in 3 patients with multiple sclerosis AU - Thomas Wehrum AU - Lena-Alexandra Beume AU - Oliver Stich AU - Irina Mader AU - Mathias Mäurer AU - Adam Czaplinski AU - Cornelius Weiller AU - Sebastian Rauer PY - 2018 JO - Neurology DO - 10.1212/wnl.0000000000004950 UR - https://doi.org/10.1212/wnl.0000000000004950 ER -
APA
Wehrum, T., Beume, L., Stich, O., Mader, I., Mäurer, M., Czaplinski, A., Weiller, C., & Rauer, S. (2018). Activation of disease during therapy with alemtuzumab in 3 patients with multiple sclerosis. Neurology. https://doi.org/10.1212/wnl.0000000000004950
Source records
- crossref · retrieved 2026-09-26T18:10:01.877Z